The human pharmacology of monocyte cyclooxygenase 2 inhibition by cortisol and synthetic glucocorticoids.

MLA

Santini, G., et al. “The Human Pharmacology of Monocyte Cyclooxygenase 2 Inhibition by Cortisol and Synthetic Glucocorticoids.” Clinical Pharmacology and Therapeutics, vol. 70, no. 5, Nov. 2001, pp. 475–83. EBSCOhost, https://doi.org/10.1067/mcp.2001.119213.

APA

Santini, G., Patrignani, P., Sciulli, M. G., Seta, F., Tacconelli, S., Panara, M. R., Ricciotti, E., Capone, M. L., & Patrono, C. (2001). The human pharmacology of monocyte cyclooxygenase 2 inhibition by cortisol and synthetic glucocorticoids. Clinical Pharmacology and Therapeutics, 70(5), 475–483. https://doi.org/10.1067/mcp.2001.119213

Chicago

Santini, G, P Patrignani, M G Sciulli, F Seta, S Tacconelli, M R Panara, E Ricciotti, M L Capone, and C Patrono. 2001. “The Human Pharmacology of Monocyte Cyclooxygenase 2 Inhibition by Cortisol and Synthetic Glucocorticoids.” Clinical Pharmacology and Therapeutics 70 (5): 475–83. doi:10.1067/mcp.2001.119213.